EVOEvotec SE
Is it safe?
Caution warranted: heavy debt (CCC) and big price swings.
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -94% · now 62% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can EVO take a bad year?
The deepest fall in EVO's price history on file is −94%; it is 62% below its high today.
Net debt · as at FY2024 · debt less the cash on hand, with no positive EBITDA to service it
- Cash runway
- 3.1 years
Cash runway · burning $25M a quarter at the current rate
- Annualised volatility
- 62%
Annualised volatility · three times the market's own swing
- Worst drawdown on file
- −94%
Worst drawdown on file · −62% today
Details›
- Total debtFY2024
- $315M
- Cash and short-term investments
- $311M
- Net debt
- $4.0M
- EBITDA, trailing twelve months
- −$41M
- Operating profit, trailing twelve months
- −$143M
- Debt / equity
- 0.33×
- Annualised volatilitytwo years of daily moves
- 62%
- Worst drawdown on file
- −94%
- Below its 52-week high
- 62%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers, Specialty & Generic
Ranks #24 of 41 by RyuScore